ADARx Pharmaceuticals, Inc. (ADRX) vs Nuvation Bio Inc. (NUVB)

ADARx Pharmaceuticals, Inc. ADRX 13.20 −0.68%
Nuvation Bio Inc. NUVB 4.17 −0.48%

ADARx Pharmaceuticals, Inc. and Nuvation Bio Inc. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Nuvation Bio Inc. are of similar size ($1.5B and $1.5B).

Metric	ADRX	NUVB	Biotechnology median
P/E	—	n/m	10.60
P/S	—	7.27	9.40
P/B	—	6.44	2.13
Price to free cash flow	—	n/m	25.18
EV/EBITDA	—	n/m	0.66
EV/Sales	—	5.40	9.02
Earnings yield	—	(9.44%)	(32.88%)
Free cash flow yield	—	(7.37%)	(23.13%)

Metric	ADRX	NUVB	Biotechnology median
Gross margin	—	85.79%	68.51%
Operating margin	—	(61.17%)	0.00%
Net margin	—	(67.38%)	0.00%
Free cash flow margin	—	(53.62%)	0.00%
Return on equity	—	(49.09%)	(51.96%)
Return on assets	—	(19.70%)	(46.06%)
Return on invested capital	—	0.00%	0.00%

Metric	ADRX	NUVB	Biotechnology median
Revenue growth (TTM)	—	654.19%	6.76%
EPS growth (last fiscal year)	—	71.56%	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ADRX	NUVB	Biotechnology median
Debt to equity	—	1.25	0.00
Current ratio	—	7.45	4.97
Net debt to EBITDA	—	2.26	1.01

Metric	ADRX	NUVB	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ADRX	NUVB	Biotechnology median
Market cap	1.47b	1.48b	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack